Buy Arcturus Therapeutics Stock | ARCT Stock Price & Latest News | Public
ARCT

Arcturus Therapeutics

$0.00 (0.00%)Today

    About ARCT

    Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.31
    -0.61
    -0.92
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.88

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,86B
    Volume84,18k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$78.88
    1 Year Low$8.51
    Open$61.28
    High$77.75
    Low$61.07

    Buy any stock with any amount of money.

    Download the App
    Download the app